Last reviewed · How we verify
C-82 Topical Gel, 1%
C-82 Topical Gel, 1% is a Small molecule drug developed by Prism Pharma Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | C-82 Topical Gel, 1% |
|---|---|
| Sponsor | Prism Pharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- C-82 Topical Gel, 1% CI brief — competitive landscape report
- C-82 Topical Gel, 1% updates RSS · CI watch RSS
- Prism Pharma Co., Ltd. portfolio CI
Frequently asked questions about C-82 Topical Gel, 1%
What is C-82 Topical Gel, 1%?
C-82 Topical Gel, 1% is a Small molecule drug developed by Prism Pharma Co., Ltd..
Who makes C-82 Topical Gel, 1%?
C-82 Topical Gel, 1% is developed by Prism Pharma Co., Ltd. (see full Prism Pharma Co., Ltd. pipeline at /company/prism-pharma-co-ltd).
What development phase is C-82 Topical Gel, 1% in?
C-82 Topical Gel, 1% is in Phase 1.
Related
- Manufacturer: Prism Pharma Co., Ltd. — full pipeline
- Compare: C-82 Topical Gel, 1% vs similar drugs
- Pricing: C-82 Topical Gel, 1% cost, discount & access